Skip to main content

Table 4 Antimicrobial administration for 150 patients over 2107 patient-days in the ICU

From: Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial—PROSPECT: a pilot trial

Daily receipt of antimicrobials, n (%) N = 2107 patient-days in ICU
 Antibiotic 1333 (63.3)
 Antifungal 192 (9.1)
 Antiviral 44 (2.1)
 Antibiotic or antifungal 1392 (66.1)
 Any antimicrobial (antibiotic or antifungal or antiviral) 1397 (66.3)
 Antimicrobial (antibiotic or antifungal) free days 715 (33.9)
Ever in ICU up to day 60, n (%) N = 150 patients
 Antibiotic received 139 (92.7)
 Antifungal received 14 (9.3)
 Antiviral received 12 (8.0)
 Antibiotic or antifungal received 139 (92.7)
 Any antimicrobial (antibiotic or antifungal or antiviral) received 140 (93.3)
 No antibiotic or antifungal ever received 11 (7.3)
Days of antimicrobial receipt, median (quartile 1 to quartile 3) N = 139 patients
 Only in patients who received the antimicrobial  
 Days on antibiotic 7 (3–12)
 Days on antifungal 10.5 (5–19)
 Days on antiviral 2 (1.5–5)
 Days on antibiotic or antifungal 8 (3–13)
 Days on any antimicrobial (antibiotic or antifungal or antiviral) 7.5 (3–12.5)